logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

D Craig Wright

This inventor holds 16 USPTO granted patents and 1 published patent application, primarily in Vaccine Development. Top assignees: Novavax, Inc., Nabi, US Government as Represented by the Secretary of the Army. Active years: 1989-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: D Craig Wright. Retrieved from https://idiyas.com/inventor/d-craig-wright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 93.8

Average Co-Inventor Count = 1.3

ph-index = 11

Forward Citations = 645(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1989 - 2002)
  • Pacific Grove, CA (US) (2008)

Company Filing History:

goldMedal11 out of 65 
 
Novavax, Inc.
 patents
silverMedal2 out of 11 
 
Nabi
 patents
bronzeMedal2 out of 8,753 
 
US Government as Represented by the Secretary of the Army
 patents
4. 1 out of 3,546 
 
University of Michigan
 patents

Years Active: 1989-2008

Loading Chart...
Areas of Expertise:
Mycobacterial Vaccine
Immunological Adjuvants
Antiviral Activity
Bacterial Inactivation
Surface Antigen
Poly Dendrimers
Oral Vaccine
Lipid Vesicles
Micellar Nanoparticles
Monoclonal Antibody
Antibacterial Emulsions
Toxoplasmic Microorganisms
16 patents (USPTO):Explore Patents
1. 7393541 - Mycobacterial vaccine (2008-07-01),
2. 6387373 - Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants (2002-05-14),
3. 6034073 - Solvent detergent emulsions having antiviral activity (2000-03-07),
4. 6015832 - Methods of inactivating bacteria including bacterial spores (2000-01-18),
5. 5961975 - Type I surface antigen associated with staphylococcus epidermidis (1999-10-05),
6. 5866140 - Type I surface antigen associated with staphylococcus epidermidis (1999-02-02),
7. 5795582 - Adjuvant properties of poly (amidoamine) dendrimers (1998-08-18),
8. 5730989 - Oral vaccine against gram negative bacterial infection (1998-03-24),
9. 5700679 - Lipid vesicles having a bilayer containing a surfactant with anti-viral (1997-12-23),
10. 5662957 - Oil containing lipid vesicles with marine applications (1997-09-02),
11. 5629021 - Micellar nanoparticles (1997-05-13),
12. 5626844 - Monoclonal antibody against ricin A chain (1997-05-06),
13. 5618840 - Antibacterial oil-in-water emulsions (1997-04-08),
14. 5549901 - Antimicrobial oil-in-water emulsions (1996-08-27),
15. 5547677 - Antimicrobial oil-in-water emulsions (1996-08-20),

Title: D Craig Wright: Innovator in Vaccine Development

Introduction

D Craig Wright is a prominent inventor based in Gaithersburg, MD (US), known for his significant contributions to the field of immunology. With a total of 16 patents to his name, he has made remarkable strides in vaccine development, particularly in combating mycobacterial infections and influenza.

Latest Patents

Among his latest patents is a mycobacterial vaccine that discloses compositions and methods for enhancing the immunity of a subject or vaccinating against mycobacterial infections. This invention provides compositions comprising formalin inactivated cultures of a mycobacterium and a Novasome® adjuvant, along with methods for utilizing these compositions. Another notable patent features an adjuvanted vaccine designed for immunizing against influenza, where the adjuvant is a lipid vesicle. This invention allows for the antigen to be encapsulated in the central cavity of the adjuvant or mixed in solution, enhancing the immune response.

Career Highlights

Throughout his career, D Craig Wright has worked with several notable companies, including Novavax, Inc. and Nabi. His work in these organizations has contributed to advancements in vaccine technology and public health.

Collaborations

D Craig Wright has collaborated with esteemed colleagues such as Joan Brisker and Ali Ibrahim Fattom, further enriching his research and development efforts in the field of immunology.

Conclusion

D Craig Wright's innovative work in vaccine development has made a significant impact on public health, showcasing his dedication to enhancing immunity against infectious diseases. His contributions continue to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…